Details of Protein
General Information of Protein (ID: PRT00266) | |||||
---|---|---|---|---|---|
Name | L-2-hydroxyglutarate dehydrogenase (L2HGDH) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Duranin; L2hgdh
|
||||
Gene Name | L2hgdh | Gene ID | |||
UniProt ID | |||||
Family | Oxidoreductases (EC 1) | ||||
EC Number | EC: 1.1.99.2 (Click to Show/Hide the Complete EC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MWPTLRYVGGVCGLARYCVAGGFLRASGPASGVPGLLCGGGRRSSSTSSFDIVIVGGGIV
GLASARTLILKHPGLSIGVVEKEKDLALHQTGHNSGVIHSGIYYKPESLKAKLCVEGAAL IYEYCNLKGIPYRQCGKLIVAVEQEEIPRLQALYERGLQNGVEGLRLIQQEDIKKKEPYC RGLMAIDCPYTGIVNYQQVALSFAQDFQEAGGSILRDFEVKGIEIAKENSSRSKDGMNYP IAVKNSKGKEIRCRYVVTCAGLYSDRISELSGCNPDPQIVPFRGDYLVLKPEKGYLVKGN IYPVPDSRFPFLGVHFTPRLDGTIWLGPNAVLAFKREGYRPFDFDARDVMEVILKSGFIN LVFQHFSYGVNEMYKACFLSETVKHLQKFIPEITISDVLRGPAGVRAQALDRDGNLVEDF VFDGGTGEIADRVLHVRNAPSPAATSSLAISRMIAEEAQQRFKL |
||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
dCMP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | dCMP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of dCMP levels compared with control group. | |||||
Organic acids and derivatives | ||||||
Alanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Alanine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of alanine levels compared with control group. | |||||
Arginine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Arginine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of arginine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Arginine concentration: increase (FC = 2.3) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the increase of arginine levels compared with control group. | |||||
Asparagine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Asparagine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of asparagine levels compared with control group. | |||||
Cysteine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Cysteine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of cysteine levels compared with control group. | |||||
Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Glutamic acid concentration: decrease (FC= 0.78) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the decrease of glutamic acid levels compared with control group. | |||||
Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Glutamine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glutamine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Glutamine concentration: decrease (FC= 0.55) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the decrease of glutamine levels compared with control group. | |||||
Glyceric acid 1,3-biphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Glyceric acid 1,3-biphosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glyceric acid 1,3-biphosphate levels compared with control group. | |||||
Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Glycine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glycine levels compared with control group. | |||||
Histidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Histidine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of histidine levels compared with control group. | |||||
L-2-Hydroxyglutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | L-2-Hydroxyglutaric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the increase of L-2-hydroxyglutaric acid levels compared with control group. | |||||
L-Homoserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | L-Homoserine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of L-homoserine levels compared with control group. | |||||
Lysine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Lysine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of lysine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Lysine concentration: increase (FC = 3.4) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the increase of lysine levels compared with control group. | |||||
Malic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of malic acid levels compared with control group. | |||||
Methionine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Methionine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of methionine levels compared with control group. | |||||
N-Acetylglutamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | N-Acetylglutamine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of N-acetylglutamine levels compared with control group. | |||||
Phenylalanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Phenylalanine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of phenylalanine levels compared with control group. | |||||
Proline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of proline levels compared with control group. | |||||
Pyruvic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Pyruvic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of pyruvic acid levels compared with control group. | |||||
Saccharopine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Saccharopine concentration: decrease (Decreased 100%) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the decrease of saccharopine levels compared with control group. | |||||
Serine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Serine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of serine levels compared with control group. | |||||
Threonine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Threonine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of threonine levels compared with control group. | |||||
Valine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Valine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of valine levels compared with control group. | |||||
Organic nitrogen compounds | ||||||
Ethanolamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of L2hgdh | |||||
Induced Change | Ethanolamine concentration: increase (FC = 1.7) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of L2hgdh leads to the increase of ethanolamine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
Dihydroxyacetone phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Dihydroxyacetone phosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of dihydroxyacetone phosphate levels compared with control group. | |||||
Fructose 1,6-bisphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Fructose 1,6-bisphosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of fructose 1,6-bisphosphate levels compared with control group. | |||||
Glyceraldehyde 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Glyceraldehyde 3-phosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glyceraldehyde 3-phosphate levels compared with control group. | |||||
Glycerol | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Glycerol concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glycerol levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
Tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Tryptophan concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of tryptophan levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.